PLK1 and colorectal carcinoma: In the CRC cohort, TMB appeared to be higher in patients harbouring PLK1 Other mutations than in those with PLK1 Pkinase (p = 0.04), PB1 (p < 0.001) or PB2 (p = 0.04) mutations (Figure 1D).